Riskpilot← Back to searchSign inGet full accessMEDPOINT AS
ASActiveOrg 925770914Sørkedalsveien 5C, 0369 OsloAllmenn legetjeneste · NACE 86211Est. 20200 employees
Revenue 2023
NOK 1K
-100% vs 2022
EBITDA margin
-3566.1%
-119% vs 2022
Equity ratio
83.2%
Financial strength
Net profit 2023
NOK -793K
-600% vs 2022
| Revenue | NOK 1K | -100% |
| EBITDA | NOK -43K | -119% |
| Net profit | NOK -793K | -600% |
| Total assets | NOK 668K | -57% |
| Equity | NOK 556K | -59% |
| Employees | 0 | — |
Legal name
MEDPOINT AS
Org number
925770914
Legal form
Aksjeselskap
NACE code
86211 · Allmenn legetjeneste
Founded
13. oktober 2020
Share capital
NOK 80 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Company purpose
Legetjenester, virksomhet innen helse, e-helse, ikt, rekruttering, konsultenvirksomhet, medvirkning i andre selskaper, kjøp, salg og forvaltning av aksjer og andeler i andre selskaper, samt alt som hører naturlig til dette. Drive legesenter, annen virksomhet innenfor helseområdet, tilby medisinske tjenester, rådgivning og undervisning.
Address
Sørkedalsveien 5C, 0369 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenue | 1 807 | 14 338 | 1 040 | 1 |
| Staff expenses | −2 | −12 | −0 | −0 |
| EBITDA | 343 | 8 126 | 227 | −43 |
| Depreciation & amort. | −0 | −16 | −18 | −18 |
| EBIT | 343 | 8 110 | 209 | −61 |
| Net financials | 0 | −6 | −4 | −735 |
| Profit before tax | 343 | 8 104 | 204 | −795 |
| Tax | 74 | 1 783 | 46 | −2 |
| Net profit | 269 | 6 321 | 159 | −793 |
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Total assets | 2 134 | 5 055 | 1 543 | 668 |
| Equity | 349 | 1 470 | 1 349 | 556 |
| Long-term debt | 0 | 6 | 2 | 0 |
| Short-term debt | 1 786 | 3 579 | 192 | 112 |
| Total debt | 1 786 | 3 586 | 194 | 112 |
EBITDA margin
-3566.1%
This company
15.8%
Market median
-22670% vs market
20202023
Equity ratio
83.2%
This company
38.2%
Market median
+118% vs market
20202023
Return on equity
-142.7%
This company
18.4%
Market median
-876% vs market
20202023
Net profit margin
-66080.0%
This company
8.1%
Market median
-815902% vs market
20202023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202023
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20202023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-10-07 – 2020-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Gullestad Medisinske Holding As | Company | 25.0% | 25.0% | 2024 |
Danzig As | Company | 25.0% | 25.0% | 2024 |
Invested As | Company | 25.0% | 25.0% | 2024 |
Anker Holding As | Company | 25.0% | 25.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Gullestad Medisinske Holding As
MEDPOINT AS Board members of MEDPOINT AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christer Torgilstveit Larsen | Board of Directors | 0 companies |
| Henrik Lind | Board of Directors | 0 companies |
| Lars Kristian Glæsel Gullestad | Board of Directors | 0 companies |
| Peder Anker | Chairman | 0 companies |
| Henrik Christer Lind | Board of Directors | 0 companies |
| Lars Kristian Gullestad | Board of Directors | 0 companies |